Clearwater Paper (CLW) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
28 Apr, 2026Executive summary
Net sales declined 5% year-over-year to $360 million for Q1 2026, with a 5% increase in shipment volumes offset by a 7% drop in average pricing.
Net loss from continuing operations was $13 million, compared to $6 million in Q1 2025, with Adjusted EBITDA at $1.9–$2 million, slightly above break-even guidance.
Severe weather events and higher input costs increased expenses and disrupted operations, impacting profitability.
Restructuring at Cypress Bend reduced workforce by 20%, targeting $8–$12 million in annual cost savings.
Launched Velora, a new lightweight folding carton paperboard brand to compete with imported FBB.
Financial highlights
Net sales were $360 million, down 5% year-over-year, with sales volumes up 5% to 302,918 tons and average net selling price down 7% to $1,101/ton.
Adjusted EBITDA margin declined to 0.5%–1% from 7.9% year-over-year.
Net loss from continuing operations was $13 million, or $1.29 per diluted share.
Cost of sales rose 6% year-over-year to $361 million, mainly due to higher maintenance, energy, and freight costs.
Received $17.5 million in insurance proceeds, with $50 million of policy limit remaining.
Outlook and guidance
Q2 2026 Adjusted EBITDA expected between breakeven and negative $10 million, impacted by a $22–$24 million major maintenance outage at Lewiston.
Full-year 2026 revenue guidance of $1.4–$1.5 billion, with flat to modest shipment growth and $70 million carryover impact from 2025 price decreases.
Productivity gains and cost reductions, including Cypress Bend restructuring, expected to offset 2%–3% of input cost inflation.
Capital expenditures projected at $65–$75 million; targeted working capital improvement of $20–$30 million.
Path to break-even or better free cash flow for the year, including insurance recoveries and a $27–$28 million tax refund.
Latest events from Clearwater Paper
- 2025 saw strong sales growth, cost savings, and major governance and ESG initiatives up for shareholder vote.CLW
Proxy filing27 Mar 2026 - Board recommends approval of all director nominees, auditor, compensation, and governance changes.CLW
Proxy filing27 Mar 2026 - Major transformation, cost savings, and ESG progress drive 2026 proxy proposals and governance.CLW
Proxy Filing5 Mar 2026 - Net sales up 12%, Adjusted EBITDA at $107M, but goodwill impairment drove a net loss.CLW
Q4 202518 Feb 2026 - Q2 net sales up 12% but net loss; tissue sale to reduce debt and boost paperboard focus.CLW
Q2 20242 Feb 2026 - Augusta mill acquisition boosts scale and reach as high utilization supports strong margins.CLW
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Augusta acquisition and tissue sale drove higher sales, debt reduction, and a paperboard focus.CLW
Q4 202422 Jan 2026 - Q3 sales and volumes rose, but margins fell; $100M buyback and debt reduction followed tissue sale.CLW
Q3 202416 Jan 2026 - Q1 net sales up 46% to $378M, with cost savings and Augusta synergies driving EBITDA growth.CLW
Q1 202523 Dec 2025